SELECT COLLABORATORS

Dr. Paula Amato

Professor of Obstetrics and Gynecology, OHSU School of Medicine. Former President, American Society for Reproductive Medicine (ASRM).

Dr. Zhongwei Huang

Deputy Director, Asia Centre for Reproductive Longevity & Equality (ACRLE), Reproductive Endocrinology and Infertility. Clinician-Scientist, Temasek Life Sciences Laboratory. Adjunct Assistant Professor, National University of Singapore.

Dr. Joshua Johnson

Associate Professor, Divisions of Reproductive Sciences & Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology

Dr. Miguel Angel Brieño-Enriquez

Assistant Professor, Magee-Womens Research Institute Department of OBGYN and Reproductive Sciences, University of Pittsburgh.

Dr. Vittorio Sebastiano

Professor of Biological Chemistry, Center for Epigenetics and Metabolism, Stem Cell Research Center, University of California, Irvine. Adjunct Professor, Stanford University. Founder and Scientific Advisory Board Chair, Turn Biotechnologies.

Dr. Diane Seimetz

Co-Founder and CEO, Biopharma Excellence (Acquired). Co-Founder, MyoPax, Avocet Bio GmbH. Executive Vice President and Chief Scientific Officer, Fresenius Group (Biotech).

Riva Tez

Researcher, writer, and angel investor. Founder, hardtowrite.com.


WRITERS 

Dr. Bérénice Benayoun

You cannot model what you never measured 

Ph.D. Associate Professor of Gerontology, Biological Sciences and Cancer Biology and Pharmacology & Pharmaceutical Sciences. PI, Benayoun Lab.

Dr. David Pépin

MenoGo: Redefining the Ovary as a Lifelong Endocrine Organ

Ph.D. Associate Professor of Surgery, Harvard Medical School. PI, Pepin Lab.

Abhishaike Mahajan

An Interview with Abhishaike Mahajan on Endometriosis

Program Officer, Public Datasets for Health, OpenAI Foundation. Founder, owlposting.com.

Dr. Levi Rybalov

ORA Ovarian Research Agent

Ph.D. Founder and CEO, Arkhai


EDITORIAL

Laura Minquini

Editor-in-chief

General Manager, AthenaBIO.

Victoria Dmitruczyk

Managing editor

Core Team, AthenaBIO. JD Candidate.

Dr. Estefano Pinilla

Scientific Editors

Assistant Professor in Cardiovascular Pharmacology at Biomedicine, Aarhus University and visiting scientist at the Baker Heart and Diabetes Institute. Science and Deal Flow Lead, AthenaBIO.

Dr. Guillherme Gatti

Scientific Editors

Research Fellow, Harvard Medical School and Massachusetts General Hospital (Brigham and Women's Hospital)

Dr. Anaelle B. Harel

Scientific Editors

Resident Doctor, University College Hospital London

Dr. Omolewa Adedipe

Scientific Editors

Clinical Program Manager, MDaaS Global.

Sidra Mujadidi

Scientific Editors

Biologist.

Lea Filipo

Designer

Designer, Huit Studio.


THANK YOU FOR THE REVIEW

Asta Diabaté

Open Innovation, Novo Nordisk

Inês Santos Silva

Core Team, AthenaBIO, Co-founder TejoMed.


BIBLIOGRPAHY

THESIS

Works Cited 

Executive Summary 

  1. Global health estimates: Leading causes of DALYs: Philippines (2021) 

  2. Global health estimates: Leading causes of DALYs: United States (2021) 

  3. Estropausal gut microbiota transplant improves measures of ovarian function in adult mice (2026)

  4. The Ovary–Brain Connection (2024)

Introduction 

  1. Artificial intelligence in drug discovery - what it is, where we stand and the path forward (2026)

  2. Family health-focused Maven Clinic raises $125M at $1.7B valuation (2024) 

  3. How This FemTech Company Just Hit Unicorn Status (2024)

  4. Midi Health reaches unicorn status with $100M raise (2026) 

  5. Pomelo Care Raises $92 Million Series C, Reaches $1.7 Billion Valuation, to Expand Its Proven Model Beyond Maternity & Set a New National Standard for Women’s and Children’s Healthcare (2026) 

  6. Closing the women’s health gap: A $1 trillion opportunity to improve lives and economies (2024)

  7. Silver Linings Bio (2026)  

  8. Dataforwomen.ai (2025)

  9. Class Action Complaint, Madison Surber v. Oura Inc (2026) 

Our Work 

  1. Roche-backed Chugai taps into longevity field with Pfizer-allied Gero (2025)

  2. AthenaBIO Reproductive Health Reports (n.d.) 

  3. Ovaries Could Unlock Secrets of Longevity (2026) 

  4. Beyond fertility and menopause: See why the ovary is central to women’s health and longevity (2025) 

Our model 

  1. Did Altos Labs just reprogram itself to focus on AI? Peter Walter, Steve Horvath, & more departures (2026)

Our commitment

  1. Closing the women’s health gap, Supra note 7

A last word on impact 

  1. Endometriosis is an interesting disease (2025) 

  1. Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy: A Data Linkage Study (2014) 

  2. Coefficient Giving’s Largest Grant Ever: $276 Million, Co-Funded With GiveWell, to the Against Malaria Foundation (2026) 

References

  1. Every disease is a policy failure (2026)

  2. Pharma Is Hollywood, Roughly (2026) 

  3. Burden of Disease (2024) 

Global health estimates: Leading causes of DALYs. Disease burden, 2000-2021 (2021)

  1. Champions for Women's Health (n.d.) 

  2. Women's Health Research Fact Sheet: We can deliver more breakthroughs in women's health — starting now. (n.d.)

  3. Opening the black box of conservation philanthropy: A co-produced research agenda on private foundations in marine conservation (2021)

  4. Nisi Ovaria: Ovarian Longevity Acceleration with AthenaDAO and GERO (2025) 

  5. UK Biobank (n.d.) 

  6. Women’s health research lacks funding – these charts show how (2023)

  7. AthenaDAO Whitepaper (2023) 

Table of contents

Next:

I

Thesis

Table of contents

Next article >

I

Thesis